معرفی
Arumugam Suyavaran is an Associate Research Scientist at Yale School of Medicine, affiliated with the Department of Digestive Diseases and Internal Medicine. His research focuses on inflammatory mechanisms in liver diseases, including hepatic ischemia-reperfusion injury, NLRP3 inflammasome activation, and mitochondrial dysfunction in fibrogenesis. He holds a PhD in Biochemistry and Molecular Biology from Pondicherry University (2017) and an MSc in the same field (2009).
Key research interests include the role of mitochondrial DNA and STING pathway in hepatic stellate cell activation, as well as the anti-inflammatory effects of compounds like digoxin and fermented soy beverages (Q-CAN® Plus). He has been recognized with awards such as the AGA GRG Basic Science Trainee Award (2023) and a Presidential poster distinction (2023).
His work integrates molecular biology, immunology, and computational approaches to study metabolic disorders (e.g., NAFLD, obesity) and alcoholic hepatitis. Collaborations include studies on multi-omics drug repositioning for NASH and proteomic biomarker identification in alcohol-associated hepatitis.
